Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07404254 · ClinicalTrials.gov registry record · NA
Effects of Variations in Caffeinated Beverages on Well-being
A NA study of Healthy and Caffeine, sponsored by Guayaki Sustainable Rainforest Products.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT07404254: Recruiting NA study of Healthy and Caffeine, sponsored by Guayaki Sustainable Rainforest Products.
NCT07404254 is a NA study of Healthy and Caffeine that is actively recruiting participants, run by Guayaki Sustainable Rainforest Products. The registered enrollment target is 75 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07404254, a NA study of Healthy and Caffeine, is actively recruiting participants, sponsored by Guayaki Sustainable Rainforest Products.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverage variations in generally healthy adults.
Primary Outcome
Participants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.
Conditions Studied
Interventions
- OTHER Caffeinated, low sugar beverage
- OTHER Caffeinated beverage
- OTHER Control beverage
Study Locations (1)
California
- Alethios, Inc. - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT07404254 shows while recruiting
NCT07404254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Caffeinated, low sugar beverage is the first listed.
NCT07404254 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07404254 about?
NCT07404254 is a clinical study titled "Effects of Variations in Caffeinated Beverages on Well-being". This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverage variations in generally healthy adults.
What is the current status of trial NCT07404254?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-01-05. Estimated completion is 2026-03-31.
What conditions does trial NCT07404254 study?
This clinical trial studies the following conditions: Healthy, Caffeine, Beverage Intake.
What interventions are being tested in trial NCT07404254?
The interventions under investigation include: Caffeinated, low sugar beverage (OTHER), Caffeinated beverage (OTHER), Control beverage (OTHER).
Who is sponsoring clinical trial NCT07404254?
This trial is sponsored by Guayaki Sustainable Rainforest Products, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07404254 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07404254's enrollment target sits among peer trials
75 300th of 1090 higher than 781 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI